Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 2, 2009, Pages 134-140

  Malik, Rohit ^a   Chhibber, Sanjay ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Bacteriophages; Burns; Klebsiella pneumoniae

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIOPHAGE; BACTERIOPHAGE K01; BLOOD ANALYSIS; BURN INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LETHAL DOSE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PERITONEUM LAVAGE; WOUND INFECTION;

ANIMALS; ASCITIC FLUID; BACTERIOPHAGES; BLOOD; BURNS; COLONY COUNT, MICROBIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MALE; MICE; SKIN; WOUND INFECTION;

EID: 67651108811     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. d'Herelle F. Sur un microbe invisible antagonistic des bacilles dysentroqes. Comptes Rendus Acad Sci Paris. 1917;165:373-375
2. Cerveny KE, DePaola A, Duckworth DH, Gulig PA. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect Immun. 2002;70:6251-6262
3. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, et al. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage fMR11. J Infect Dis. 2003;18:353-358
4. Wills QF, Kerrigan C, Soothil JS. Experimental bacteriophage protection against Staphylococcus aureus abysses in a rabbit model. Antimicrob Agents Chemother. 2005;49:1220-1221
5. Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S, Brüssow H. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy. Antimicrob Agents Chemother. 2004;48:2558-2569
6. Smith HW, Huggins MW. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol. 1982;128:307-318
7. Smith HW, Huggins MW. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol. 1983;129:2659-2675
8. Smith HW, Huggins MW, Shaw KM. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol. 1987;133:1127-1135
9. Smith HW, Huggins MW, Shaw KM. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol. 1987;133:1111-1126
10. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA. 1996;93:3188-3192
11. Soothill JS. Treatment of experimental infections of mice with bacteriophages. J Med Microbiol. 1992;37:258-261
12. Berchieri A, Lovell MA, Barrow PA. The activity in the chicken alimentary tract of bacteriophages lytic for Salmonella Typhimurium. Res Microbiol. 1991;142:541-549
13. Soothill JS. Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns. 1994;20:209-211
14. Ahmad SI. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Med Hypotheses. 2002;58:327-331
15. Ioseliani GD, Meladze GD, Chkhetiia NS, Mebuke MG, Kiknadze NI. Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases. Grudn Khir. 1980;6:63-67 [Article in Russian].
16. Meladze GD, Mebuke MG, Chkhetia NS, Kiknadze NI, Koguashvili GG, Timoshuk II, et al. The efficacy of staphylococcal bacteriophage in treatment of purulent diseases of lungs and pleura. Grudn Khir. 1982;1:53-56 [Article in Russian].
17. Perepanova TS, Darbeeva OS, Kotliarova GA, Kondrat'eva EM, Maiskaia LM, Malysheva VF, et al. The efficacy of bacteriophage preparations in treating inflammatory urologic diseases. Urol Nefrol. 1995;5:14-17
18. Kaczkowski H, Weber-Dabrowska B, Dabrowski M, Zdrojewicz Z, Cwioro F. Use of bacteriophages in the treatment of chronic bacterial diseases. Wiad Lek. 1990;43:136-141 [Article in Polish].
19. Kwarcinski W, Lazarkiewicz B, Weber-Dabrowska B, Rudnicki J, Kaminski K, Sciebura M. Bacteriophage therapy in the treatment of recurrent subphrenic and subhepatic abscess with jejunal fistula after stomach resection. Pol Tyg Lek. 1994;49:535. [Article in Polish].
20. Stroj L, Weber-Dabrowska B, Partyka K, Mulczyk M, Wojcik M. Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn. Neurol Neurochir Pol. 1999;3:693-698
21. Nathan P, Holder IA, Mac Millan BG. Burn wounds: microbiology, local host defenses, and current therapy. Crit Rev Clin Lab Sci. 1973;4:61-100.
22. Casewell MW, Martin SM, Dixon RE. Aspects of plasmid mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med. 1981;70:459-462
23. Yadav V, Sharma S, Harjai K, Mohan H, Chhibber S. Induction and resolution of lobar pneumonia following intranasal instillation with Klebsiella pneumoniae in mice. Indian J Med Res. 2003;118:47-52.
24. Adams MH. Bacteriophages. New York: Interscience Publishers; 1959.
25. Dale RM, Schnel G, Wong JP. Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2004;48:2918-2923
26. Busch JM, Chess J, Friedman NB. Pneumoniae due to Bacilli friedlanderi. Arch Intern Med. 2000;60:735-739
27. Adamia RS, Matitashvili EA, Kvachadze LI, Korinteli VI, Matoyan DA, Kutateladze MI, et al. The virulent bacteriophage IRA of Salmonella Typhimurium: cloning of phage genes which are potentially lethal for the host cell. J Basic Microbiol. 1990;30:707-716
28. Appelmans R. Le bacteriophage dans l'organisme. Comp Rend Soc Biol. 1921;85:722-724
29. Evans AC. Inactivation of antistreptococcus bacteriophage by animal fluids. Public Health Rep. 1933;48:411-426
30. Bogovazova GG, Voroshilova NN, Bondarenko VM. The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection. Zh Mikrobiol Epidemiol Immunobiol. 1991;5:8-11. [Article in Russian].
31. Bogovazova GG, Voroshilova NN, Bondarenko VM, Gorbatkova GA, Afanaseva EV, Kazakova TB, et al. Immunobiological properties and therapeutic effectiveness of preparations from Klebsiella bacteriophages. Zh Mikrobiol Epidemiol Immunobiol. 1992;5:30-33 [Article in Russian].
32. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing method and pathogenicity factors. Clin Microbiol Rev. 1998;11:589-603.